Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine vs Dronedarone vs Amiodarone for Post-CABG AF Prophylaxis
NCT03905759Phase 3Unknown
- Start
- Apr 2019
- Primary completion
- Apr 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of colchicine and dronedarone in Atrial fibrillation (AFib) (3 arms). Primary endpoint: Incidence of Postoperative Atrial Fibrillation at 6 days. Status: unknown.
02
Drugs
colchicinedronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03905759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03905759.